Skin Care Active to Treat Acne and Skin Pigmentation

Mar 11, 2011 | Contact Author | By: Katie Schaefer
Contact the Author
Save
This item has been saved to your library.
View My Library
(click to close)
Save to My Library
Title: Skin Care Active to Treat Acne and Skin Pigmentation
  • Article

At In-Cosmetics in Milan, Rovi Cosmetics will launch two actives for skin care. While UniTone (INCI: Not Provided) is designed to lighten skin pigmentation, Herbapurifine (INCI: Not Provided) aims to treat acneic skin.

The skin lightening active Unitone is said to inhibit tyrosinase activity. The company notes that melanogenisis takes place in the melanocytes in the basal layer; therefore, a delivery system is required to allow actives designed to inhibit tyrosinase activity to reach the melanocytes. The company employed its Ineocell technology, which is said to deliver the actives directly into the melanocytes. Furthermore, the skin lightening active reportedly reduces the skin‘s intracellular and extracellular melanin content. In vivo, using intravitaltomography, the active was shown reduce the melanin content in the strata basale et spinosum by 95.5% in 14 days. 

The company's second introduction, Herbapurifine, was created to inhibit pro-inflammatory proteins and Propionibacterium acnes using magnolia and willow bark. Furthermore, this Ecocert-approved, anti-acne active reportedly reduces comedones, papules and pustules by 35.2% and sebum production by 20% in four weeks while relieving itchiness and imparting a soft skin feel